Multiple sclerosis: from basic immunopathology to immune intervention.
Miller
Ariel
A
Neuroimmunology Research Unit, Carmel Medical Center, Rappaport Institute for Research in the Medical Sciences & Faculty of Medicine, Technion - Isreal Institute of Technology, Haifa 34362, Israel. millera@tx.technion.ac.il
Galboiz
Yanina
Y
D000917:Antibody Formation; D017209:Apoptosis; D002448:Cell Adhesion; D002465:Cell Movement; D016207:Cytokines / Q000494:pharmacology* / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007249:Inflammation; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010951:Plasma Exchange; D013601:T-Lymphocytes / Q000276:immunology*
D016207:Cytokines; D007136:Immunoglobulins; D018696:Neuroprotective Agents